Literature DB >> 6987307

Separation of a serum-derived tumoricidal factor from a helper factor for plaque-forming cells.

D N Männel, J J Farrar, S E Mergenhagen.   

Abstract

C3H/HeN mice administered BCG followed by lipopolysaccharide 14 days later released into their serum a cytotoxic factor for tumor cells and a factor that restored the anti-SRBC plaque-forming cell response of nude mouse spleen cells (helper activity). Gel filtration of serum containing the cytotoxic and the helper activities indicated that both factors exhibited an apparent m.w. of 125,000 to 150,000. The helper activity was also found at lower m.w. (60,000 and 13,000) suggesting the possibility that this factor existed in aggregated forms. Gel filtration of ammonium sulfate (40 to 60% saturation) precipitated serum in a high ionic strength buffer (1.6 M NaCl) resulted in shifts in the apparent m.w. of both factors. The cytotoxic factor now exhibited a m.w. of 55,000. The helper activity eluted with an apparent m.w. of 13,000, and thus was clearly separated from the cytotoxic factor. The helper activity was further shown to co-elute with macrophage-derived lymphocyte activating factor (LAF). This as well as other data represent the first demonstration of in vivo produced LAF.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6987307

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Suggested importance of monokines in pathophysiology of endotoxin shock and malaria.

Authors:  I A Clark
Journal:  Klin Wochenschr       Date:  1982-07-15

2.  Experimental approaches to the identification of immunologically active soluble factors produced in vivo.

Authors:  L S English
Journal:  Surv Immunol Res       Date:  1984

Review 3.  Regulation of macrophage accessory functions by interactions involving lymphokines and endotoxin.

Authors:  R N Moore
Journal:  Klin Wochenschr       Date:  1982-07-15

4.  Possible role of endotoxin in mediating host resistance.

Authors:  D N Männel
Journal:  Klin Wochenschr       Date:  1982-07-15

5.  Macrophages as a source of tumoricidal activity (tumor-necrotizing factor).

Authors:  D N Männel; R N Moore; S E Mergenhagen
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

6.  Growth inhibitors in plasma derived human serum.

Authors:  D A Pigott; M A Grimaldi; M L Dell'Aquila; E V Gaffney
Journal:  In Vitro       Date:  1982-07

7.  Possible importance of macrophage-derived mediators in acute malaria.

Authors:  I A Clark; J L Virelizier; E A Carswell; P R Wood
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

8.  Production of lymphocyte activating factor in vivo.

Authors:  P R Wood; L Andrus; I A Clark
Journal:  Immunology       Date:  1983-12       Impact factor: 7.397

9.  Generation and characterization of a lipopolysaccharide-induced and serum-derived cytotoxic factor for tumor cells.

Authors:  D N Männel; M S Meltzer; S E Mergenhagen
Journal:  Infect Immun       Date:  1980-04       Impact factor: 3.441

10.  Synergistic action of human recombinant tumor necrosis factor with endotoxins or nontoxic poly A:U against solid Meth A tumors in mice.

Authors:  N Bloksma; F M Hofhuis
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.